Aragen Biologics Profile
Key Indicators
- Authorised Capital ₹ 245.00 Cr
- Paid Up Capital ₹ 146.00 Cr
- Company Age 1 Year 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 140.00 Cr
About Aragen Biologics
Aragen Biologics Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 June 2023 (One year and eight months 4 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 245.00 Cr and a paid-up capital of Rs 146.00 Cr.
The company currently has active open charges totaling ₹140.00 Cr.
Manmahesh Kantipudi and Gunapati Keshav serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U21001TS2023PTC174243
- Company No.
174243
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2023
- Date of AGM
24 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Aragen Biologics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manmahesh Kantipudi  | Director | 21-Jun-2023 | Current |
| Gunapati Keshav | Director | 21-Jun-2023 | Current |
Financial Performance of Aragen Biologics.
Aragen Biologics Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aragen Biologics?
In 2024, Aragen Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zeroharm Sciences Private LimitedManmahesh Kantipudi is a mutual person
Aragen Life Sciences LimitedManmahesh Kantipudi and Gunapati Keshav are mutual person
Aavishkar Oral Strips Private LimitedGunapati Keshav is a mutual person
Aragen FoundationManmahesh Kantipudi and Gunapati Keshav are mutual person
Intox Private LimitedManmahesh Kantipudi is a mutual person
Zeroharm Prerna Private LimitedManmahesh Kantipudi is a mutual person
Charges (Loans)
₹140.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 140.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2024 | Citi Bank N.A. | ₹120.00 Cr | Open |
| 30 May 2024 | Citi Bank N.A. | ₹20.00 Cr | Open |
How Many Employees Work at Aragen Biologics?
Unlock and access historical data on people associated with Aragen Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aragen Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aragen Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
